vs
BRUNSWICK CORP(BC)とNEUROCRINE BIOSCIENCES INC(NBIX)の財務データ比較。上の社名をクリックして会社を切り替えられます
BRUNSWICK CORPの直近四半期売上が大きい($1.3B vs $805.5M、NEUROCRINE BIOSCIENCES INCの約1.7倍)。NEUROCRINE BIOSCIENCES INCの純利益率が高く(19.1% vs 1.4%、差は17.7%)。NEUROCRINE BIOSCIENCES INCの前年同期比売上増加率が高い(28.3% vs 15.5%)。NEUROCRINE BIOSCIENCES INCの直近四半期フリーキャッシュフローが多い($386.0M vs $83.6M)。過去8四半期でNEUROCRINE BIOSCIENCES INCの売上複合成長率が高い(25.0% vs -1.1%)
ブランズウィック・コーポレーションは1845年創業の米国企業で、多種多様な製品の開発・製造・販売を行っている。Mercury Marineをはじめとする複数のブランドを保有し、24カ国に1万3000人以上の従業員が在籍し、2024年の売上高は52億米ドル、世界本社はイリノイ州シカゴ北部郊外のメタワに所在する。
ニューロクライン・バイオサイエンシズは1992年設立の米国バイオ医薬品企業で、本社をカリフォルニア州サンディエゴに置く。2024年10月現在のCEOはカイル・ガノで、神経系・内分泌系疾患の治療薬を開発している。2017年には遅発性ジスキネジアの成人患者向け治療薬「イングレッザ(一般名:バルベナジン)」が米国で承認された。
BC vs NBIX — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $1.3B | $805.5M |
| 純利益 | $18.7M | $153.7M |
| 粗利率 | 23.1% | 97.8% |
| 営業利益率 | 3.1% | 26.2% |
| 純利益率 | 1.4% | 19.1% |
| 売上前年比 | 15.5% | 28.3% |
| 純利益前年比 | 122.7% | 49.1% |
| EPS(希薄化後) | $0.32 | $1.49 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.3B | $805.5M | ||
| Q3 25 | $1.4B | $794.9M | ||
| Q2 25 | $1.4B | $687.5M | ||
| Q1 25 | $1.2B | $572.6M | ||
| Q4 24 | $1.2B | $627.7M | ||
| Q3 24 | $1.3B | $622.1M | ||
| Q2 24 | $1.4B | $590.2M | ||
| Q1 24 | $1.4B | $515.3M |
| Q4 25 | $18.7M | $153.7M | ||
| Q3 25 | $-235.5M | $209.5M | ||
| Q2 25 | $59.3M | $107.5M | ||
| Q1 25 | $20.2M | $7.9M | ||
| Q4 24 | $-82.5M | $103.1M | ||
| Q3 24 | $44.6M | $129.8M | ||
| Q2 24 | $100.0M | $65.0M | ||
| Q1 24 | $68.0M | $43.4M |
| Q4 25 | 23.1% | 97.8% | ||
| Q3 25 | 25.8% | 98.2% | ||
| Q2 25 | 25.5% | 98.4% | ||
| Q1 25 | 24.9% | 98.4% | ||
| Q4 24 | 21.9% | 98.5% | ||
| Q3 24 | 26.2% | 98.7% | ||
| Q2 24 | 27.1% | 98.4% | ||
| Q1 24 | 27.4% | 98.5% |
| Q4 25 | 3.1% | 26.2% | ||
| Q3 25 | -17.8% | 30.1% | ||
| Q2 25 | 7.1% | 21.2% | ||
| Q1 25 | 4.6% | 4.1% | ||
| Q4 24 | -4.8% | 22.6% | ||
| Q3 24 | 7.7% | 29.5% | ||
| Q2 24 | 11.0% | 24.6% | ||
| Q1 24 | 8.1% | 19.3% |
| Q4 25 | 1.4% | 19.1% | ||
| Q3 25 | -17.3% | 26.4% | ||
| Q2 25 | 4.1% | 15.6% | ||
| Q1 25 | 1.7% | 1.4% | ||
| Q4 24 | -7.1% | 16.4% | ||
| Q3 24 | 3.5% | 20.9% | ||
| Q2 24 | 6.9% | 11.0% | ||
| Q1 24 | 5.0% | 8.4% |
| Q4 25 | $0.32 | $1.49 | ||
| Q3 25 | $-3.59 | $2.04 | ||
| Q2 25 | $0.89 | $1.06 | ||
| Q1 25 | $0.30 | $0.08 | ||
| Q4 24 | $-1.21 | $1.00 | ||
| Q3 24 | $0.67 | $1.24 | ||
| Q2 24 | $1.48 | $0.63 | ||
| Q1 24 | $0.99 | $0.42 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $256.8M | $713.0M |
| 総負債低いほど良い | $2.1B | — |
| 株主資本純資産 | $1.6B | $3.3B |
| 総資産 | $5.3B | $4.6B |
| 負債/資本比率低いほどレバレッジが低い | 1.30× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $256.8M | $713.0M | ||
| Q3 25 | $297.7M | $340.2M | ||
| Q2 25 | $315.7M | $264.0M | ||
| Q1 25 | $286.7M | $194.1M | ||
| Q4 24 | $269.0M | $233.0M | ||
| Q3 24 | $284.1M | $349.1M | ||
| Q2 24 | $494.5M | $139.7M | ||
| Q1 24 | $548.4M | $396.3M |
| Q4 25 | $2.1B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.6B | $3.3B | ||
| Q3 25 | $1.6B | $3.0B | ||
| Q2 25 | $1.9B | $2.7B | ||
| Q1 25 | $1.9B | $2.5B | ||
| Q4 24 | $1.9B | $2.6B | ||
| Q3 24 | $2.0B | $2.7B | ||
| Q2 24 | $2.0B | $2.5B | ||
| Q1 24 | $2.0B | $2.4B |
| Q4 25 | $5.3B | $4.6B | ||
| Q3 25 | $5.4B | $4.3B | ||
| Q2 25 | $5.8B | $3.9B | ||
| Q1 25 | $5.9B | $3.7B | ||
| Q4 24 | $5.7B | $3.7B | ||
| Q3 24 | $6.0B | $3.5B | ||
| Q2 24 | $6.4B | $3.3B | ||
| Q1 24 | $6.5B | $3.5B |
| Q4 25 | 1.30× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.25× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $132.9M | $388.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $83.6M | $386.0M |
| FCFマージンFCF / 売上 | 6.3% | 47.9% |
| 設備投資強度設備投資 / 売上 | 3.7% | 0.3% |
| キャッシュ転換率営業CF / 純利益 | 7.11× | 2.53× |
| 直近12ヶ月FCF直近4四半期 | $396.3M | $743.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $132.9M | $388.4M | ||
| Q3 25 | $140.4M | $227.5M | ||
| Q2 25 | $316.2M | $102.0M | ||
| Q1 25 | $-27.4M | $64.8M | ||
| Q4 24 | $306.4M | $242.5M | ||
| Q3 24 | $67.4M | $158.0M | ||
| Q2 24 | $211.0M | $64.6M | ||
| Q1 24 | $-153.4M | $130.3M |
| Q4 25 | $83.6M | $386.0M | ||
| Q3 25 | $106.5M | $214.3M | ||
| Q2 25 | $271.3M | $89.5M | ||
| Q1 25 | $-65.1M | $54.1M | ||
| Q4 24 | $276.1M | $235.2M | ||
| Q3 24 | $31.4M | $149.9M | ||
| Q2 24 | $163.9M | $53.0M | ||
| Q1 24 | $-207.4M | $119.1M |
| Q4 25 | 6.3% | 47.9% | ||
| Q3 25 | 7.8% | 27.0% | ||
| Q2 25 | 18.7% | 13.0% | ||
| Q1 25 | -5.3% | 9.4% | ||
| Q4 24 | 23.9% | 37.5% | ||
| Q3 24 | 2.5% | 24.1% | ||
| Q2 24 | 11.4% | 9.0% | ||
| Q1 24 | -15.2% | 23.1% |
| Q4 25 | 3.7% | 0.3% | ||
| Q3 25 | 2.5% | 1.7% | ||
| Q2 25 | 3.1% | 1.8% | ||
| Q1 25 | 3.1% | 1.9% | ||
| Q4 24 | 2.6% | 1.2% | ||
| Q3 24 | 2.8% | 1.3% | ||
| Q2 24 | 3.3% | 2.0% | ||
| Q1 24 | 4.0% | 2.2% |
| Q4 25 | 7.11× | 2.53× | ||
| Q3 25 | — | 1.09× | ||
| Q2 25 | 5.33× | 0.95× | ||
| Q1 25 | -1.36× | 8.20× | ||
| Q4 24 | — | 2.35× | ||
| Q3 24 | 1.51× | 1.22× | ||
| Q2 24 | 2.11× | 0.99× | ||
| Q1 24 | -2.26× | 3.00× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
BC
| Engine Partsand Accessories | $532.4M | 40% |
| Navico Group | $452.9M | 34% |
| Recreational Fiberglass Boats | $111.6M | 8% |
| Saltwater Fishing Boats | $85.7M | 6% |
| Controls Riggingand Propellers | $78.3M | 6% |
| Business Acceleration | $48.1M | 4% |
| Sterndrive Engine | $32.6M | 2% |
NBIX
| INGREZZA Net Product Sales | $653.8M | 81% |
| CRENESSITY Net Product Sales | $135.4M | 17% |
| Other Income | $12.6M | 2% |
| Collaboration Revenue | $7.2M | 1% |